Everyone Healthy Library
Fragile X Associated Tremor Ataxia Syndrome
Condition / disease reference page from the Everyone Healthy database.
Connected health information
Explore this condition in a clear order
Linked signs and symptoms
10Each sign/symptom opens its own page and links back to related conditions.
Linked drugs / medications
0No linked drugs are listed yet.
Treatments, therapies and supportive options
6Grouped by treatment type. These are educational database links, not personal treatment recommendations. Evidence labels are shown only where stored in the EH database.
Alternative and complementary therapies
3Vitamins and minerals
1Vitamins
1Linked diagnostic tests and investigations
0No linked diagnostic tests are listed yet.
Biological and test markers
0This visual map uses existing EH database links to show biological agents and lab markers reported as increased, decreased, or associated with this condition. These are educational relationships only; test results must be interpreted by a qualified clinician because ranges vary by lab, method, age, sex and clinical context.
No biological marker links are listed yet for this condition.
Introduction / full article
Fragile X Associated Tremor Ataxia Syndrome
Fragile X Associated Tremor Ataxia Syndrome
This is a condition that usually involves those over the age of 50. Fragile X Associated Tremor Ataxia Syndrome (FXTAS) causes concerns in physical and mental ability. Symptoms worsen as those with FXTAS get older. FXTAS can cause muscles to tremble during voluntary movement. There can also be concerns with balancing and coordination. Those with FXTAS can also have concerns with sensations, weakened muscles, or tingling pain. Mental ability or cognition is affected, which is evident through memory loss or problems in solving problems. FXTAS is more common in men. Though a large number of people are affected by FXTAS, only a percentage develops signs.
Efficacy of Alternative and Other Treatments According to GRADE* Ranking:
Folic Acid [1, 2, 3, 4]:
Please note, this management does NOT treat the condition itself. It is proposed only as a weak supportive symptomatic support, and even then, has insufficient evidence to back up this claim at present.
Recommendation: Weakly in favor (Studies show that folic acid may be beneficial to those with FXTAS. More studies are needed)
Grade of Evidence: Low quality of evidence
* www.gradeworkinggroup.org
Summary Reference
Treatments:
1. http://www.ncbi.nlm.nih.gov/pubmed/16047089
2. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2546470/
3. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350386/
4. http://www.ncbi.nlm.nih.gov/books/NBK1384/